Literature DB >> 16563832

Molecular genetics of RH and its clinical application.

W A Flegel1.   

Abstract

BACKGROUND: The RH genes RHD and RHCE encode two proteins that represent the clinically most important blood group system defined by the sequences of red cell membrane proteins. In the last five years the field has been moving from defining the underlying molecular genetics to applying the molecular genetics in clinical practice.
MATERIALS AND METHODS: The state of the current knowledge is briefly summarized using recent reviews and original work since 2000.
RESULTS: The RHD and RHCE genes are strongly homologous and located closely adjacent at the human chromosomal position 1p36.11. Part of the genetic complexity is explained by the clustered orientation of both genes with their tail ends facing each other. The SMP1 gene is located interspersed between both RH genes. Using additional genetic features of the RH gene locus, RHCE was shown to represent the ancestral RH position, while RHD is the duplicated gene. More than 150 alleles have been defined for RHD alone. They were classified based on antigenic and clinical properties into phenotypes like partial D, weak D and DEL. Among the D negative phenotype a large variety of non-functional alleles were found. The frequencies of these distinct alleles vary widely among human populations, which has consequences for clinical practice.
CONCLUSION: Rhesus is a model system for the correlation of genotype and phenotype, facilitating the understanding of underlying genetic mechanisms in clustered genes. With regard to clinical practice, the genetic diagnostics of blood group antigens will advance the cost-effective development of transfusion medicine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563832     DOI: 10.1016/j.tracli.2006.02.011

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  13 in total

1.  [Genotyping of RhD-negative blood samples diagnosed by serological tests from patients waiting for kidney transplantation].

Authors:  Shao-Jie Fu; Yan-Lin Feng; Li-Xin Yu; Yun Miao; Min Luo; Yi-Bin Wang; Yi-Chen Li; Shu-Han Chen; Lu-Lu Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

2.  Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients.

Authors:  Pu Xu; Yan Li; Hua Yu
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

3.  Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran.

Authors:  Mohammad Hossein Ahmadi; Sedigheh Hantuoshzadeh; Mohammad Ali Okhovat; Nahid Nasiri; Azita Azarkeivan; Naser Amirizadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2015-11-06       Impact factor: 0.900

4.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

5.  Screening for DEL phenotype in RhD negative Indians.

Authors:  Swati Kulkarni; Disha S Parchure; Vidya Gopalkrishnan; Manisha Madkaikar
Journal:  J Clin Lab Anal       Date:  2017-06-23       Impact factor: 2.352

6.  Systematic RH genotyping and variant identification in French donors of African origin.

Authors:  Sandrine Kappler-Gratias; Carine Auxerre; Isabelle Dubeaux; Marylise Beolet; Maryline Ripaux; Pierre-Yves Le Pennec; Bach-Nga Pham
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

Review 7.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

8.  It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.

Authors:  Willy A Flegel; Gregory A Denomme; John T Queenan; Susan T Johnson; Margaret A Keller; Connie M Westhoff; Louis M Katz; Meghan Delaney; Ralph R Vassallo; Clayton D Simon; S Gerald Sandler
Journal:  Transfusion       Date:  2020-03-12       Impact factor: 3.337

9.  Toxoplasmosis-associated difference in intelligence and personality in men depends on their Rhesus blood group but not ABO blood group.

Authors:  Jaroslav Flegr; Marek Preiss; Jiří Klose
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

10.  Rhesus factor modulation of effects of smoking and age on psychomotor performance, intelligence, personality profile, and health in Czech soldiers.

Authors:  Jaroslav Flegr; Jan Geryk; Jindra Volný; Jiří Klose; Dana Cernochová
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.